SKELETAL ADVERSE EVENTS ASSOCIATED WITH IMMUNE CHECKPOINT INHIBITORS: EMERGING TRENDS FROM THE US FOOD AND DRUG ADMINISTRATION ADVERSE EVENT REPORTING SYSTEM

被引：0
|
作者：
Pundole, X. [1 ]
Sarangdhar, M. [2 ]
Suarez-Almazor, M. E. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN259
引用
收藏
页码：S486 / S486
页数：1
相关论文
共 50 条
  • [1] RHEUMATIC AND MUSCULOSKELETAL ADVERSE EVENTS ASSOCIATED WITH IMMUNE CHECKPOINT INHIBITORS: DATA MINING OF THE US FOOD AND DRUG ADMINISTRATION ADVERSE EVENT REPORTING SYSTEM
    Pundole, X.
    Sarangdhar, M.
    Suarez-Almazor, M. E.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 147 - 148
  • [2] Immune Checkpoint Inhibitors and Inflammatory Myopathies: Data from the US Food and Drug Administration Adverse Event Reporting System
    Pundole, Xerxes
    Shah, Mohsin
    Abdel-Wahab, Noha
    Suarez-Almazor, Maria
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [3] Common Immune-Related Adverse Events of Immune Checkpoint Inhibitors in the Gastrointestinal System: A Study Based on the US Food and Drug Administration Adverse Event Reporting System
    Bai, Xiaoyin
    Jiang, Shiyu
    Zhou, Yangzhong
    Zhen, Hongnan
    Ji, Junyi
    Li, Yi
    Ruan, Gechong
    Yang, Yang
    Shen, Kaini
    Wang, Luo
    Li, Guanqiao
    Yang, Hong
    [J]. FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [4] Serious Cutaneous Toxicities with Immune Checkpoint Inhibitors in the US Food and Drug Administration Adverse Event Reporting System
    Raschi, Emanuel
    Antonazzo, Ippazio Cosimo
    La Placa, Michelangelo
    Ardizzoni, Andrea
    Poluzzi, Elisabetta
    De Ponti, Fabrizio
    [J]. ONCOLOGIST, 2019, 24 (11): : E1228 - E1231
  • [5] Adverse events reported to the US Food and Drug Administration Adverse Event Reporting System for tisagenlecleucel
    Dores, Graca M.
    Jason, Christopher
    Niu, Manette T.
    Perez-Vilar, Silvia
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (09) : 1087 - 1100
  • [6] Hepatic failure associated with immune checkpoint inhibitors: An analysis of the Food and Drug Administration Adverse Event Reporting System database
    Xu, Ye
    Yan, Cilin
    Zhao, Ying
    Li, Dandan
    Guo, Mingxing
    Cui, Xiangli
    [J]. CANCER MEDICINE, 2023, 12 (08): : 9167 - 9174
  • [7] Investigating bleeding adverse events associated with BTK inhibitors in the food and drug administration adverse event reporting system (FAERS)
    Li, Xianlin
    Shang, Nan
    Yan, Qianci
    Yue, Xiunan
    Liu, Yang
    Zheng, Xiaojun
    [J]. EXPERT OPINION ON DRUG SAFETY, 2024,
  • [8] Adverse Events Associated with Use of Digoxin Immune Fab Reported to the US Food and Drug Administration Adverse Event Reporting System, 1986–2019
    Shaokui Wei
    Manette T. Niu
    Graça M. Dores
    [J]. Drugs - Real World Outcomes, 2021, 8 : 253 - 262
  • [9] Hepatotoxicity Associated with Immune Checkpoint Inhibitors in Clinical Practice: A Study Leveraging Data from the US Food and Drug Administration's Adverse Event Reporting System
    Yang, Hui
    Wang, Haozhou
    Zhou, Xiaoguang
    Zhang, Xiaodong
    [J]. CLINICAL THERAPEUTICS, 2023, 45 (02) : 151 - 159
  • [10] Reporting of immune-related adverse events (irAEs) in US Food and Drug Administration (FDA) approvals of immune checkpoint inhibitors
    Tapiavala, Shaili
    Shenouda, Mina A.
    Patel, Vaibhav G.
    Davis, Andrew A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345